Jefferies Group’s Esperion Therapeutics ESPR Stock Holding History

Jefferies Group’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-9,008	Closed	-$253K	–	1755
2021 Q1	$253K	Buy	+9,008	New	+$266K	﹤0.01%	1292
2020 Q1	–	Sell	-10,000	Closed	-$596K	–	2209
2019 Q4	$596K	Sell	10,000 -9,463	-49%	-$425K	﹤0.01%	1709
2019 Q3	$714K	Buy	19,463 +11,112	+133%	+$440K	0.01%	1686
2019 Q2	$388K	Buy	+8,351	New	+$392K	﹤0.01%	1794
2015 Q1	–	Sell	-7,300	Closed	-$471K	–	2176
2014 Q4	$295K	Buy	+7,300	New	+$223K	﹤0.01%	1555

Other funds holding ESPR

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return